NCT01336920 - Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 21, 2011

Primary Completion Date

April 1, 2015

Study Completion Date

March 1, 2018

Conditions

Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaPeripheral T-cell LymphomaRecurrent Adult T-cell Leukemia/Lymphoma

Interventions

DRUG

carfilzomib

Given IV

Trial Locations (3)

30322

Emory University, Winship Cancer Institute, Atlanta

68198

University of Nebraska Medical Center, Omaha

77030

M D Anderson Cancer Center, Houston